Prions of yeast, [PSI] and [URE3], as models for neurodegenerative diseases

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 61, Issue , 1996, Pages 541-550

  Wickner, R B ^a   Masison, D C ^a   Edskes, H K ^a   Maddelein, M L ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AMYLOIDOSIS; CONFERENCE PAPER; DEGENERATIVE DISEASE; NONHUMAN; POLYNEUROPATHY; PRION; PRIORITY JOURNAL; PYRIMIDINE SYNTHESIS; SACCHAROMYCES CEREVISIAE; AMES TEST; AMINO TERMINAL SEQUENCE; ARTICLE; BRAIN SPONGIOSIS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DELETION MUTANT; DOUBLE-STRANDED RNA VIRUS; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; MOLECULAR GENETICS; MOLECULAR PHYLOGENY; PHENOTYPE; PROMOTER REGION; REPLICON; RIBOSOME; SCRAPIE AGENT; TWO HYBRID SYSTEM; WILD TYPE;

SACCHAROMYCES CEREVISIAE;

CELL PROTEIN; GALI PROTEIN; GUANIDINE; MITOCHONDRIAL DNA; PRION PROTEIN; PROTEINASE K; PSI PROTEIN; SUP35P PROTEIN; TRANSFER RNA; UNCLASSIFIED DRUG; URE2P PROTEIN; URE3 PROTEIN; VIRUS ENVELOPE PROTEIN;

EID: 0030438372     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.1996.061.01.054     Document Type: Conference Paper

References (57)

1. Aigle, M. and F. Lacroute. 1975. Genetical aspects of [URE3], a non-Mendelian, cytoplasmically inherited mutation in yeast. Mol. Gen. Genet. 136: 327.
2. Alper, T., W.A. Cramp, D.A. Haig, and M.C. Clarke. 1967. Does the agent of scrapie replicate without nucleic acid? Nature 214: 764.
3. Bessen, R. A., D.A. Kocisko, G.J. Raymond, S. Nandan, P.T. Landsbury, and B. Caughey. 1995. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375: 698.
4. Bolton, D.C., M.P. McKinley, and S.B. Prusiner. 1982. Identification of a protein that purifies with the scrapie prion. Science 218: 1309.
5. Brandner, S., S. Isenmann, A. Raeber, M. Fischer, A. Sailer, Y. Kobayashi, S. Marino, C. Weissmann, and A. Aguzzi. 1996. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379: 339.
6. Büeler, H., M. Fischer, Y. Lang, H. Bluethmann, H.P. Lipp, S.J. DeArmond, S.B. Prusiner, M. Aguet, and C. Weissmann. 1992. Normal-development and behavior of mice lacking the neuronal cell-surface PrP protein. Nature 356: 577.
7. Caughey, B. 1991. Cellular metabolism of normal and scrapie-associated forms of PrP. Semin. Virol. 2: 189.
8. Chernoff, Y.O., I.L. Derkach, and S.G. Inge-Vechtomov. 1993. Multicopy SUP35 gene induces de-novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae. Curr. Genet. 24: 268.
9. +]. Science 268: 880.
10. Cooper, T.G. 1982. Nitrogen metabolism in Saccharomyces cerevisiae. In The molecular biology of the yeast Saccharomyces: Metabolism and gene expression (ed. J.N. Strathern et al.), p. 39. Cold Spring Harbor Laboratory, Cold Spring Harbor, New york.
11. Coschigano, P.W. and B. Magasanik. 1991. The URE2 gene product of Saccharomyces cerevisiae plays an important role in the cellular response to the nitrogen source and has homology to glutathione S-transferases. Mol. Cell. Biol. 11: 822.
12. Cox, B.S. 1965. PSI, a cytoplasmic suppressor of supersuppressor in yeast. Heredity 20: 505.
13. _. 1971. A recessive lethal super-suppressor mutation in yeast and other PSI phenomena. Heredity 26: 211.
14. Cox, B.S., M.F. Tuite, and C.S. McLaughlin. 1988. The Psi factor of yeast: A problem in inheritance. Yeast 4: 159.
15. Cummins, C.M., R.F. Gaber, M.R. Culbertson, R. Mann, and G.R. Fink. 1980. Frameshift suppression in Saccharomyces cerevisiae. III. Isolation and genetic properties of group III suppressors. Genetics 95: 855.
16. Didichenko, S.A., M.D. TerAvanesyan, and V.N. Smirnov. 1991. Ribosome-bound EF-1 alpha-like protein of yeast Saccharomyces cerevisiae. Eur. J. Biochem. 198: 705.
17. Diringer, H., H. Gelderblom, H. Hilmert, M. Ozel, C. Edelbluth, and R.H. Kimberlin. 1983. Scrapie infectivity, fibrils and low molecular weight protein. Nature 306: 476.
18. - mutation which eliminates the [PSI] factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 137: 659.
19. Drillien, R. and F. Lacroute. 1972. Ureidosuccinic acid uptake in yeast and some aspects of its regulation. J. Bacteriol. 109: 203.
20. Drillien, R., M. Aigle, and F. Lacroute. 1973. Yeast mutants pleiotropically impaired in the regulation of the two glutamate dehydrogenases. Biochem. Biophys. Res. Commun. 53: 367.
21. Eustice, D.C., L.P. Wakem, J.M. Wilhelm, and F. Sherman. 1986. Altered 40S ribosomal subunits in omnipotent suppressors of yeast. J. Mol Biol. 188: 207.
22. Fischer, M., T. Rulicke, A. Raeber, A. Sailer, M. Moser, B. Oesch, S. Brandner, A. Aguzzi, and C. Weissmann. 1996. Prion protein (PrP) with amino-terminal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15: 1255.
23. Griffith, J.S. 1967. Self-replication and scrapie. Nature 215: 1043.
24. Hawthorne, D.C. and R.K. Mortimer. 1968. Genetic mapping of nonsense suppressors in yeast. Genetics 60: 735.
25. Hsiao, K.K., M. Scott, D. Foster, D.F. Groth, S.J. DeArmond, and S.B. Prusiner, 1990. Spontaneous neurodegeneration in transgenic mice with mutant prion protein of Gerstmann-Straussler syndrome. Science 250: 1587.
26. Hsiao, K.K., D. Groth, M. Scott, S.-L. Yang, H. Serban, D. Rapp, D. Foster, M. Torchia, S.J. DeArmond, and S.B. Prusiner. 1994. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc. Natl. Acad. Sci. 91: 9126.
27. Kitamoto, T., R. Iizuka, and J. Tateishi. 1993. An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques. Biochem. Biophys. Res. Commun. 192: 525.
28. Kocisko, D.A., S.A. Priola, G.J. Raymond, B. Chesebro, P.T. Landsbury, and B. Caughey. 1995 Species specificity in the cell-free conversion of prion protein to protease-resistant forms: A model for the scrapie species barrier. Proc. Natl. Acad. Sci. 92: 3923.
29. Kocisko, D.A., J.H. Come, S.A. Priola, B. Chesebro, G.J. Raymond, P.T. Lansbury, and B. Caughey. 1994. Cell-free formation of protease-resistant prion protein. Nature 370: 471.
30. Kushnirov, V.V., M.D. Ter-Avanesyan, M.V. Telckov, A.P. Surguchov, V.N. Smirnov, and S.G. Inge-Vechtomov. 1988. Nucleotide sequence of the SUP2(SUP35) gene of Saccharomyces cerevisiae. Gene 66: 45.
31. Lacroute, F. 1971. Non-Mendelian mutation allowing ureidosuccinic acid uptake in yeast. J. Bacteriol. 106: 519.
32. Leibman, S.W., J.W. Stewart, and F. Sherman. 1975. Serine substitutions caused by an ochre suppressor in yeast. J. Mol. Biol. 94: 595.
33. Magasanik, B. 1992. Regulation of nitrogen utilization. In The molecular and cellular biology of the yeast Saccharomyces: Gene expression (ed. E.W. Jones et al.), p. 283. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
34. Masison, D.C. and R.B. Wickner. 1995. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 270: 93.
35. Mortimer, R.K. and D.C. Hawthorne. 1966. Genetic mapping in Saccharomyces. Genetics 53: 165.
36. Oesch, B., D. Westaway, M. Walchli, M.P. McKinley, S.B. Kent, R. Aebersold, R.A. Barry, P. Tempst, D.B. Teplow, L.E. Hood, S.B. Prusiner, and C. Weissmann. 1985. A cellular gene encodes scrapie PrP 27-30 protein. Cell 40: 735.
37. Palmer E., J. Wilhelm, and F. Sherman. 1979. Phenotypic suppression of nonsense mutants in yeast by aminoglycoside antibiotics. Nature 277: 148.
38. Parsell, D.A., A.S. Kowal, M.A. Singer, and S. Lindquist. 1994. Protein disaggregation mediated by heat-shock protein Hsp104. Nature 372: 475.
39. +] determinant is mediated by oligomerization of the SUP35-encoded potypeptide chain release factor. EMBO J. 15: 3127.
40. Prusiner, S.B. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216: 136.
41. Singh, A.C., C. Helms, and F. Sherman. 1979. Mutation of the non-Mendelian suppressor [PSI] in yeast by hypertonic media. Proc. Natl. Acad. Sci. 76: 1952.
42. Stansfield, I., K.M. Jones, V.V. Kushnirov, A.R. Dagkesamanskaya, A.I. Poznyakovski, S.V. Paushkin, C.R. Nierras, B.S. Cox, M.D. Ter-Avanesyan, and M.F. Tuite. 1995. The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae EMBO J. 14: 4365.
43. Tamm, I. and H.J. Eggers. 1963. Specific inhibition of replication of animal viruses. Science 142: 24.
44. +] in the yeast Saccharomyces cerevisiae. Genetics 137: 671.
45. -] cell-free lysates of Saccharomyces cerevisiae. Proc. Natl. Acad Sci. 80: 2824.
46. -] strains of yeast. FEBS Lett. 225: 205.
47. -] in Saccharomyces cerevisiae. Genetics 98: 691.
48. Turoscy, V. and T.G. Cooper. 1987. Ureidosuccinate is transported by the allantoate transport system in Saccharomyces cerevisiae. J. Bacteriol. 169: 2598.
49. UCA. Nucleic Acids Res. 9: 3077.
50. Westaway, D., S.J. DeArmond, J. Cayetano-Canlas, D. Groth, D. Foster, S.-L. Yang, M. Torchia, G.A. Carlson, and S.B. Prusiner. 1994. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76: 117.
51. Wickner, R.B. 1994. Evidence for a prion analog in S. cerevisiae: The [URE3] non-Mendelian genetic element as an altered URE2 protein. Science 264: 566.
52. _. 1996a. Double-stranded RNA viruses of yeast. Microbiol. Rev. 60: 250.
53. _. 1996b. Prions and RNA viruses of Saccharomyces cerevisiae. Annu. Rev. Genet. 30: (in press).
54. _. 1996c. Viruses of yeasts, fungi and parasitic microorganisms. Fields virology (ed. B.N. Fields et al.), p. 557. Raven Press, New York.
55. Wickner, R.B. and D.C. Masison. 1996. Evidence for two prion diseases in yeast: [URE3] and [PSI]. Curr. Top. Microbiol. Immunol. 207: 147.
56. Wilson, P.G. and M.R. Culbertson. 1988. SUF12 suppressor protein of yeast: A fusion protein related to the EF-1 family of elongation factors. J. Mol. Biol. 199: 559.
57. Zhouravleva, G., L. Frolova, X. LeGoff, R. LeGuellec, S. Inge-Vectomov, L. Kisselev, and M. Philippe. 1995. Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J. 14: 4065.